Wallisch Jessica S, Simon Dennis W, Bayır Hülya, Bell Michael J, Kochanek Patrick M, Clark Robert S B
Department of Critical Care Medicine, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Neurocrit Care. 2017 Aug;27(1):44-50. doi: 10.1007/s12028-017-0378-7.
Inflammasome-mediated neuroinflammation may cause secondary injury following traumatic brain injury (TBI) in children. The pattern recognition receptors NACHT domain-, Leucine-rich repeat-, and PYD-containing Protein 1 (NLRP1) and NLRP3 are essential components of their respective inflammasome complexes. We sought to investigate whether NLRP1 and/or NLRP3 abundance is altered in children with severe TBI.
Cerebrospinal fluid (CSF) from children (n = 34) with severe TBI (Glasgow coma scale score [GCS] ≤8) who had externalized ventricular drains (EVD) placed for routine care was evaluated for NLRP1 and NLRP3 at 0-24, 25-48, 49-72, and >72 h post-TBI and was compared to infection-free controls that underwent lumbar puncture to rule out CNS infection (n = 8). Patient age, sex, initial GCS, mechanism of injury, treatment with therapeutic hypothermia, and 6-month Glasgow outcome score were collected.
CSF NLRP1 was undetectable in controls and detected in 2 TBI patients at only <24 h post-TBI. CSF NLRP3 levels were increased in TBI patients compared with controls at all time points, p < 0.001. TBI patients ≤4 years of age had higher peak NLRP3 levels versus patients >4 (15.50 [3.65-25.71] vs. 3.04 [1.52-8.87] ng/mL, respectively; p = 0.048). Controlling for initial GCS in multivariate analysis, peak NLRP3 >6.63 ng/mL was independently associated with poor outcome at 6 months.
In the first report of NLRP1 and NLRP3 in childhood neurotrauma, we found that CSF NLRP3 is elevated in children with severe TBI and independently associated with younger age and poor outcome. Future studies correlating NLRP3 with other markers of inflammation and response to therapy are warranted.
炎性小体介导的神经炎症可能导致儿童创伤性脑损伤(TBI)后的继发性损伤。模式识别受体含NACHT结构域、富含亮氨酸重复序列和PYD结构域的蛋白1(NLRP1)和NLRP3是其各自炎性小体复合物的重要组成部分。我们试图研究严重TBI患儿中NLRP1和/或NLRP3丰度是否发生改变。
对34例因常规护理而放置脑室外引流管(EVD)的严重TBI患儿(格拉斯哥昏迷量表评分[GCS]≤8)的脑脊液(CSF)在TBI后0 - 24小时、25 - 48小时、49 - 72小时和>72小时进行NLRP1和NLRP3评估,并与接受腰椎穿刺以排除中枢神经系统感染的无感染对照组(n = 8)进行比较。收集患者的年龄、性别、初始GCS、损伤机制、亚低温治疗情况以及6个月时的格拉斯哥预后评分。
对照组脑脊液中未检测到NLRP1,仅在2例TBI患者TBI后<24小时检测到。在所有时间点,TBI患者的脑脊液NLRP3水平均高于对照组,p < 0.001。4岁及以下的TBI患者的NLRP3峰值水平高于4岁以上患者(分别为15.50[3.65 - 25.71]对3.04[1.52 - 8.87]ng/mL;p = 0.048)。在多变量分析中,控制初始GCS后,NLRP3峰值>6.63 ng/mL与6个月时的不良预后独立相关。
在关于儿童神经创伤中NLRP1和NLRP3的首次报告中,我们发现严重TBI患儿的脑脊液NLRP3升高,且与年龄较小和不良预后独立相关。未来有必要开展将NLRP3与其他炎症标志物及治疗反应相关联的研究。